Kerri Miller

Minden

Host, Talking Volumes at Minnesota Public Radio (St. Paul, MN)

Host at MPR News with Kerri Miller

Host of Big Books & Bold Ideas, a show about books & reading on MPR News. Follow @thethreadmpr for all things books.

Featured in: Favicon

mpr.org

rsc.org

mprnews.org Favicon

tallahassee.com Favicon

kuow.org

pewtrusts.org Favicon

chemistryworld.com Favicon

newsbreak.com Favicon

jacionline.org Favicon

northernpublicradio.org + 7 more

Articles

Tirzepatide Tops Semaglutide for Weight Loss

2 days ago | conexiant.com | Kerri Miller

In a head-to-head randomized trial of adult patients with obesity, tirzepatide achieved a 20.2% mean reduction in body weight compared with 13.7% with semaglutide at 72 weeks, according to results from the SURMOUNT-5 trial. In the 72-week, phase IIIb, multicenter, open-label, randomized trial, researchers evaluated the safety and efficacy of tirzepatide vs semaglutide in 751 adult patients with obesity but without type 2 diabetes.
Early Antibiotics Impact Puberty Timing, Study

2 days ago | conexiant.com | Kerri Miller

Girls exposed to antibiotics during their first year of life—particularly within the first 3 months—face a significantly higher risk of developing central precocious puberty, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology and the European Society of Endocrinology in Copenhagen.
GLP-1s May Protect Against Obesity-Related Cancer

2 days ago | conexiant.com | Kerri Miller

First-generation GLP-1 receptor agonists provide comparable protection against obesity-related cancers as bariatric surgery in patients with obesity and diabetes, according to the results of an observational, retrospective cohort study. Researchers conducted a matched cohort study of 3,178 pairs of patients with obesity and diabetes who received either first-generation GLP-1 RAs or underwent bariatric metabolic surgery (BMS) between 2010 and 2018.
Yearly Blood Tests May Cut Cancer Deaths by 21%

3 days ago | conexiant.com | Kerri Miller

According to a recent study, researchers have demonstrated that annual blood-based multicancer early detection screening could significantly reduce both late-stage cancer diagnoses and cancer mortality. In the study, researchers from Cambridge University Hospitals National Health Service Foundation Trust, GRAIL, and Queen Mary University of London evaluated how different screening intervals could affect cancer detection and mortality outcomes.
Facemasks Detect CKD via Breath Biomarkers?

3 days ago | conexiant.com | Kerri Miller

Researchers have developed a disposable array of gas sensors integrated into standard FFP2 facemasks that can identify patients with chronic kidney disease by analyzing their breath composition with significant accuracy. The innovative device, which leverages porphyrin-based sensors to detect ammonia and other volatile compounds associated with kidney dysfunction, achieved identification of patients with chronic kidney disease with 93.3% true positives and 86.7% true negatives.
Delayed Puberty: Diabetes Risk Signal?

3 days ago | conexiant.com | Kerri Miller

A new study has identified delayed puberty in adolescent males as a significant independent risk factor for developing early-onset type 2 diabetes, regardless of body weight or socioeconomic factors.
Hand Movements Reveal Autism's Kinematic Signature

6 days ago | conexiant.com | Kerri Miller

New research demonstrated that analyzing simple finger movements during grasping tasks can accurately distinguish between autistic and nonautistic individuals, offering potential for an accessible diagnostic approach.
mRNA Combo Vaccine Effective Against Respiratory Viruses

6 days ago | conexiant.com | Kerri Miller

A phase III randomized clinical trial has demonstrated that mRNA-1083, an investigational multicomponent mRNA vaccine targeting seasonal influenza and SARS-CoV-2, met noninferiority immunogenicity criteria compared with licensed standard-of-care vaccines in adults aged 50 years and older. Researchers also found that mRNA-1083 induced superior immune responses against multiple vaccine-matched strains in some subgroups, while maintaining an acceptable safety profile.
Cystic Fibrosis: New Evidence-Based Guidelines for Newborn Screening

1 week ago | conexiant.com | Kerri Miller

The Cystic Fibrosis Foundation has published the first comprehensive, consensus-driven guidelines aimed at improving the consistency, equity, and efficacy of newborn screening for cystic fibrosis across the United States, marking the first standardized recommendations for CF newborn screening programs.
Shorter Prostate Radiotherapy Proves Long-Term Match

1 week ago | conexiant.com | Kerri Miller

A phase III clinical trial demonstrated that an ultra-hypofractionated radiotherapy regimen delivered over 2.5 weeks may be as safe and effective as the conventional 8-week course for treating localized prostate cancer, with comparable outcomes sustained through 10 years of follow-up.